Álvaro Beltrán‐Corbellini

Author

Hospital Universitario Ramón y Cajal ORCID

Also Known As

Alvaro Beltran-Corbellini, Alvaro Beltrán-Corbellini, Alvaro Beltrán‐Corbellini, Fernando Rodríguez-Jorge, J. L. Chico-García, Lauren Bolden, Á. Beltrán‐Corbellini, Álvaro Beltran-Corbellini, Álvaro Beltrán-Corbellini, Álvaro Beltrán‐Corbellini

Publications

948

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario Ramón y Cajal Hospital Ruber Internacional Hospital Clínico San Carlos University of Southern Denmark Epilepsy Foundation

ÁB

About

Álvaro Beltrán‐Corbellini is an author at Hospital Universitario Ramón y Cajal specializing in medicine, clinical epidemiology, and epidemiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	126
2	Public Health	2	2	70
3	Health Sciences	1	1	18
4	Language Studies	1	1	18
5	Social Sciences	1	1	17

Álvaro Beltrán‐Corbellini

Publications

612

Citations

H-Index

Page 1

	Year	Citations
Acute‐onset smell and taste disorders in the context of COVID‐19: a pilot multicentre polymerase chain reaction based case–control study Álvaro Beltrán‐Corbellini, Juan Luis Chico‐García, Javier Martínez‐Poles, European Journal of Neurology	2020	382
High versus standard doses of corticosteroids in severe COVID-19: a retrospective cohort study Enric Monreal, Susana Sainz de la Maza, Elena Natera‐Villalba, European Journal of Clinical Microbiology & Infectious Diseases Retrospective Cohort StudyLong CovidCovid-19 PandemicClinical EpidemiologySevere Covid-19	2020	59
Anakinra and tocilizumab in the chronic phase of febrile infection-related epilepsy syndrome (FIRES): Effectiveness and safety from a case-series Ángel Aledo‐Serrano, Roshan Hariramani, Alicia González‐Martínez, Seizure MedicineChronic PhaseClinical EpidemiologyAntibiotics	2022	39
Cenobamate in patients with highly refractory focal epilepsy: A retrospective real-world study Álvaro Beltrán‐Corbellini, María Romeral‐Jiménez, Irene Sánchez‐Miranda Román, Seizure Refractory Focal EpilepsyNeurologyRetrospective Real-world Study	2023	32
SURINPARK: Safinamide for Urinary Symptoms in Parkinson’s Disease Ana Gómez‐López, Arantxa Sánchez‐Sánchez, Elena Natera‐Villalba, Brain Sciences	2021	20
Loss of regional accent after damage to the speech production network Marcelo L. Berthier, Guadalupe Dávila, Ignacio Moreno‐Torres, Frontiers in Human Neuroscience Acquired AphasiaRegional AccentSpeech SamplesPhonologySpeech Production Network	2015	18
Effect of fenfluramine on seizures and comorbidities in <scp><i>SCN8A</i>‐developmental</scp> and epileptic encephalopathy: A case series Ángel Aledo‐Serrano, B. Cabal-Paz, Elena Gardella, Epilepsia Open	2022	17
D-galactose Supplementation for the Treatment of Mild Malformation of Cortical Development with Oligodendroglial Hyperplasia in Epilepsy (MOGHE): A Pilot Trial of Precision Medicine After Epilepsy Surgery Ángel Aledo‐Serrano, Adrián Valls Carbó, Christina Fenger, Neurotherapeutics Mild MalformationNeurobiology Of DiseaseD-galactose SupplementationNeurologyNeuroscience	2023	17
Efficacy and tolerability of add‐on stiripentol in real‐world clinical practice: An observational study in Dravet syndrome and non‐Dravet developmental and epileptic encephalopathies António Gil‐Nagel, Ángel Aledo‐Serrano, Álvaro Beltrán‐Corbellini, Epilepsia Open	2023	17
Non‐severe immunosuppression might be associated with a lower risk of moderate–severe acute respiratory distress syndrome in COVID‐19: A pilot study Enric Monreal, Sainz de la Maza S, Pedro Gullón, Journal of Medical Virology Acute Lung InjuryRespiratory Distress Syndrome (Pulmonary Critical Care)Covid-19 EpidemiologyCovid-19Pilot Study	2020	11

Page 1